Merck/AstraZeneca Stay Tied To Each Other For Another Two Years

Merck and AstraZeneca continue a 30-year partnership after coming to terms that could benefit both companies.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet